NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 318 filers reported holding NOVOCURE LTD in Q2 2022. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,747,196 | -4.9% | 417,783 | +144.4% | 0.00% | -100.0% |
| Q2 2023 | $7,092,971 | -74.0% | 170,915 | -62.4% | 0.00% | -66.7% |
| Q1 2023 | $27,326,352 | -18.6% | 454,379 | -0.7% | 0.00% | 0.0% |
| Q4 2022 | $33,564,814 | +32.4% | 457,598 | +37.2% | 0.00% | +50.0% |
| Q3 2022 | $25,345,000 | +59.1% | 333,558 | +45.6% | 0.00% | +100.0% |
| Q2 2022 | $15,926,000 | -25.9% | 229,134 | -11.7% | 0.00% | -50.0% |
| Q1 2022 | $21,506,000 | -11.8% | 259,594 | -20.1% | 0.00% | -33.3% |
| Q4 2021 | $24,392,000 | -43.5% | 324,876 | -12.5% | 0.00% | -40.0% |
| Q3 2021 | $43,138,000 | -31.1% | 371,340 | +31.5% | 0.01% | -16.7% |
| Q2 2021 | $62,626,000 | +72.2% | 282,327 | +2.6% | 0.01% | +50.0% |
| Q1 2021 | $36,373,000 | -15.4% | 275,187 | +10.7% | 0.00% | -20.0% |
| Q4 2020 | $42,996,000 | +63.8% | 248,480 | +5.4% | 0.01% | +25.0% |
| Q3 2020 | $26,245,000 | +150.2% | 235,784 | +33.3% | 0.00% | +100.0% |
| Q2 2020 | $10,491,000 | -34.8% | 176,914 | -26.0% | 0.00% | -33.3% |
| Q1 2020 | $16,102,000 | +60.7% | 239,111 | +101.2% | 0.00% | +200.0% |
| Q4 2019 | $10,017,000 | -2.8% | 118,862 | -13.8% | 0.00% | -50.0% |
| Q3 2019 | $10,306,000 | +97.7% | 137,823 | +67.2% | 0.00% | +100.0% |
| Q2 2019 | $5,213,000 | -13.1% | 82,448 | -33.8% | 0.00% | 0.0% |
| Q1 2019 | $5,998,000 | +195.3% | 124,515 | +105.3% | 0.00% | – |
| Q4 2018 | $2,031,000 | -21.4% | 60,657 | +23.1% | 0.00% | – |
| Q3 2018 | $2,583,000 | -11.4% | 49,279 | -47.1% | 0.00% | – |
| Q2 2018 | $2,914,000 | -62.7% | 93,070 | -74.0% | 0.00% | -100.0% |
| Q1 2018 | $7,813,000 | +341.4% | 358,413 | +309.0% | 0.00% | – |
| Q4 2017 | $1,770,000 | +74.4% | 87,635 | +71.4% | 0.00% | – |
| Q3 2017 | $1,015,000 | +83.9% | 51,141 | +60.5% | 0.00% | – |
| Q2 2017 | $552,000 | +81.0% | 31,863 | -15.1% | 0.00% | – |
| Q1 2017 | $305,000 | +67.6% | 37,531 | +61.7% | 0.00% | – |
| Q4 2016 | $182,000 | +85.7% | 23,210 | +101.5% | 0.00% | – |
| Q3 2016 | $98,000 | -36.8% | 11,518 | -13.0% | 0.00% | – |
| Q2 2016 | $155,000 | +3000.0% | 13,232 | +4022.1% | 0.00% | – |
| Q1 2016 | $5,000 | -76.2% | 321 | -66.5% | 0.00% | – |
| Q4 2015 | $21,000 | – | 959 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
| HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
| Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
| MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
| Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
| Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
| Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
| Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
| Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |